DermTech Competitors and Similar CompaniesClear all

DermTech's competitors and similar companies include Fulgent Genetics.
DermTech
DermTech
DermTech is a diagnostics company developing and marketing non-invasive gene expression tests.
Fulgent Genetics
Fulgent Genetics
Fulgent Therapeutics is a technology company offering large-scale COVID-19 testing services, molecular diagnostic testing services, and comprehensive genetic testing.
Founding Date
Founding Date
1996
Founding Date
2011
Type
Type
Public
Type
Public
Tags
Locations
Locations
San Diego, US HQ
Locations
Temple City, US HQ
Houston, US
Employees
Employees
60
Employees
1,01257% increase
Valuation ($)
Valuation ($)
3.3 m
Valuation ($)
606.8 m

Financial

Revenue (est.)
Revenue (est.)
$15.3m (FY, 2023)
Revenue (est.)
$322.7m (FY, 2025)
Cost of goods
Cost of goods
$15m (FY, 2023)
Cost of goods
$191.8m (FY, 2025)
Gross profit
Gross profit
$276k (FY, 2023)
Gross profit
$130.9m (FY, 2025)
Net income
Net income
($100.9m) (FY, 2023)
Net income
($61.6m) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 5.6m
Total funding raised
$ 34.9m
For sources of this data, please see the company profile

View Company Profiles

Fulgent Genetics
HQ
Temple City, US
Employees
1,012

Fulgent Therapeutics is a technology company offering large-scale COVID-19 testing services, molecular diagnostic testing services, and comprehensive genetic testing.

View company